At its April 2025 meeting, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) gave conditional marketing authorization for Oczyesa (octreotide) for the ...
Dr. Céline Gounder, an internist, epidemiologist and infectious disease specialist, is a CBS News medical contributor as well as senior fellow and editor-at-large for public health at KFF Health News.
HRT can also be a concern after treatment. If you’ve been treated for HR+ breast cancer, “There is always some small risk ...
US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels on hormone replacement therapy, following testimony from experts who said ...
Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, the Food and Drug Administration announced Monday. In the ...
Marie Claire on MSN
Let's stop fear-mongering hormone therapy, okay?
For years, women have been told to “tough it out” through menopause—doctors are finally calling BS.
Testosterone is being sold as the missing hormone for midlife women. Except there's no FDA-approved female dose, so sourcing and dosing has become the Wild West. How did we get here, and what comes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results